Waters Crecimiento futuro

Future controles de criterios 1/6

Waters se prevé un crecimiento anual de los beneficios y los ingresos de 6.1% y 3.9% respectivamente. Se prevé que el BPA sea de grow en 7.9% al año. Se prevé que la rentabilidad de los fondos propios sea de 28.3% en 3 años.

Información clave

6.5%

Tasa de crecimiento de los beneficios

8.1%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Life Sciences	0%
Tasa de crecimiento de los ingresos	4.2%
Rentabilidad financiera futura	31.6%
Cobertura de analistas	Good
Última actualización	17 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Previsiones de crecimiento de beneficios e ingresos

BOVESPA:WATC34 - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	3,339	777	805	975	10
12/31/2025	3,165	727	766	945	18
12/31/2024	2,983	658	725	894	18
12/31/2023	2,956	642	442	603	N/A
9/30/2023	2,995	653	390	571	N/A
7/1/2023	2,992	675	387	572	N/A
4/1/2023	2,966	689	425	610	N/A
12/31/2022	2,972	708	428	612	N/A
10/1/2022	2,950	697	465	631	N/A
7/2/2022	2,901	702	477	641	N/A
4/2/2022	2,868	705	565	727	N/A
12/31/2021	2,786	693	579	747	N/A
10/2/2021	2,736	695	626	797	N/A
7/3/2021	2,671	660	642	802	N/A
4/3/2021	2,509	616	697	857	N/A
12/31/2020	2,365	522	618	791	N/A
9/26/2020	2,295	504	536	715	N/A
6/27/2020	2,278	515	495	691	N/A
3/28/2020	2,358	537	430	619	N/A
12/31/2019	2,407	592	479	643	N/A
9/28/2019	2,405	577	491	633	N/A
6/29/2019	2,406	580	475	631	N/A
3/30/2019	2,403	591	467	604	N/A
12/31/2018	2,420	594	508	604	N/A
9/29/2018	2,392	55	489	615	N/A
6/30/2018	2,380	51	536	623	N/A
3/31/2018	2,342	27	611	699	N/A
12/31/2017	2,309	20	607	698	N/A
9/30/2017	2,251	548	N/A	679	N/A
7/1/2017	2,212	537	N/A	674	N/A
4/1/2017	2,190	533	N/A	656	N/A
12/31/2016	2,167	522	N/A	643	N/A
10/1/2016	2,125	498	N/A	623	N/A
7/2/2016	2,099	490	N/A	613	N/A
4/2/2016	2,057	467	N/A	567	N/A
12/31/2015	2,042	469	N/A	573	N/A
10/3/2015	2,040	469	N/A	568	N/A
7/4/2015	2,032	467	N/A	557	N/A
4/4/2015	2,019	457	N/A	550	N/A
12/31/2014	1,989	432	N/A	512	N/A
9/27/2014	1,971	422	N/A	493	N/A
6/28/2014	1,935	406	N/A	470	N/A
3/29/2014	1,904	399	N/A	473	N/A
12/31/2013	1,904	450	N/A	485	N/A
9/28/2013	1,861	484	N/A	473	N/A
6/29/2013	1,853	485	N/A	470	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: WATC34's forecast earnings growth (6.7% per year) is below the tasa de ahorro (9.6%).

Beneficios vs. Mercado: WATC34Se prevé que los beneficios de la empresa (6.7% al año) crezcan menos que el mercado BR (14.6% al año).

Beneficios de alto crecimiento: WATC34Se prevé que los beneficios de la empresa crezcan, pero no significativamente.

Ingresos vs. Mercado: WATC34(4.8% al año) se prevé que crezca más despacio que el mercado de BR (6.3% al año).

Ingresos de alto crecimiento: WATC34Se prevé que los ingresos de la empresa (4.8% al año) crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: WATC34se prevé que la Rentabilidad de los fondos propios sea alta dentro de 3 años (28.3%)

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Waters Crecimiento futuro

Future controles de criterios 1/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Waters Corporation Provides Earnings Guidance for the First Quarter and Full-Year 2024

Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023

Waters Corporation Provides Earnings Guidance for the Second Quarter of 2023 and Fiscal Year 2023

Waters Corporation Provides Earnings Guidance for the First Quarter of 2023 and Fiscal Year 2023

Waters Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Waters Corporation Provides Earnings Guidance for the Third Quarter Ending October 1, 2022 and Full Year Ending December 31, 2022

Recent updates

Waters Corporation, Annual General Meeting, May 23, 2024

Waters Corporation Provides Earnings Guidance for the First Quarter and Full-Year 2024

Waters Corporation Announces Resignation of Jonathan Pratt as Senior Vice President of the Waters Division

Waters Corporation Launched OligoWorks SPE Workflow and Kits

Waters Corporation Introduces DynaPro™? ZetaStar™? Instrument from its Wyatt Technology™? Portfolio for Nanoparticle Analysis

Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023

Waters Corporation Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications

Waters Corporation Boosts Resolution and Triples Scan Speed of Select Series MRT for Metabolomics and MS Imaging

Waters Corporation Provides Earnings Guidance for the Second Quarter of 2023 and Fiscal Year 2023

Waters Corporation Provides Earnings Guidance for the First Quarter of 2023 and Fiscal Year 2023

Waters Corporation Announces Waters_Connect™ System Monitoring

Waters Corporation Announces Executive Changes

Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors

Waters Introduces New PFAS Quantitation Workflow Enabled by Enhancements to Waters_Connect Informatics Platform

Waters Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot

Waters Extends Capabilities of Flagship Ta Instruments Rheometer for Efficient and Repeatable Powder Analysis

Waters Corporation Provides Earnings Guidance for the Third Quarter Ending October 1, 2022 and Full Year Ending December 31, 2022

Waters Corporation to Report Q2, 2022 Results on Aug 02, 2022

Waters Corporation(NYSE:WAT) dropped from Russell 1000 Value-Defensive Index

Waters Corporation Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development

Waters Corporation Provides Earnings Guidance for the Quarter Ending July 2, 2022 and Full Year Ending December 31, 2022

Waters Corporation, Annual General Meeting, May 24, 2022

Waters Corporation Announces Resignation of John Ballbach from the Board of Directors

Waters Introduces Xevo TQ Absolute

Waters Corporation Provides Earnings Guidance for the First Quarter Ending April 2, 2022 and Year Ending December 31, 2022

Waters Corporation Introduces the Waters™ BioAccord™ System

Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2021

Waters Corporation Introduces TRIOS AutoPilot Software

Waters Corp. Introduces the Waters Arc Premier System

Waters Corporation Introduces the Sars-Cov-2 Lc-Ms Kit (Ruo) to Advance Clinical Research of Infectious Diseases

Waters Corporation Provides Earnings Guidance for the Three Months Ended July 3, 2021 and for the Full Year Ended December 31, 2021

Waters Corporation Introduces A New Peptide Multi-Attribute Method Workflow for the Waters BioAccord LC-MS System

Waters Corporation Improves Ease and Reliability of Small Molecule Analysis with ACQUITY RDa Detector

Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link

Waters Corporation Introduces the OttoTM SPEcialist Positive Pressure Manifold

Waters Corporation's APGC-MS/MS System Accepted for Advanced Dioxin and Furan Analysis Following USEPA Approval of SGS AXYS Method 16130

Waters Corporation Appoints Pearl S. Huang to Board of Directors

Waters Corporation Announces CFO Changes

Megadalton Solutions, Inc. Announces Expansion of Collaboration with Waters Corporation

Waters Corporation Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact RADIAN ASAP System

Waters Corporation Introduces Acquity Premier Columns

Waters Corporation (NYSE: WAT) signed an agreement to acquire rheology instruments and services business of Rheometric Scientific, Inc. for $23 million.

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento